 |
|
 |
The NFKB/REL/IK B paradigm
Inder Verma
The Salk Institute, USA
|
|
 |
Role of Fas-induced apoptosis in diseases
polymerase transcription
Shigekazu Nagata
Osaka Univ. Medical School, Japan
|
|
|
|
|
 |
Regulation of phospholipase C isozymes
Sue-Goo Rhee
National Institutes of Health, USA
|
|
 |
Cellular signaling by tyrosine phosphorylation
polymerase transcription
Joseph Schlessinger
Yale Univ School of Medicine,. USA
|
|
|
|
|
 |
The molecular biology of ATP-sensitive potassium channels
Joseph Bryan
Baylor College of Medicine, USA
|
|
 |
Defective G protein-coupled signal transduction as a cause of human disease polymerase transcription
Allen M. Spiegel
National Institutes of Health, USA
|
|
|
|
|
 |
Cytokine signal transduction in health and disease
Tadamitsu Kishimoto
Osaka Univ. Medical School, Japan
|
|
 |
Defective G protein-coupled signal transduction as a cause of human disease
polymerase transcription
Timothy Hoey
Tularik Inc., USA
|
|
|
|
|
 |
The RB pathway and its clinical relevance
William F. Benedict
MD Anderson Cancer Center, USA
|
|
 |
Novel neurotrophic-myotrophic-angiogenic growth factors: Biological roles and signaling capabilitiesn
George D. Yancopoulos
Regeneron Pharmaceuticals, USA
|
|
|
|
|
 |
TGF-ет: Physiological action and clinical applications
Seong-Jin Kim
National Cancer Institute, USA
|
|
 |
Identification of receptors in the cardiovascular system as targets for drug discovery
Jeffrey M. Stadel
SmithKline Beecham Pharmeceuticals, USA
|
|
|
|
|
 |
p53 gene therapy of cancer : Application to hepatocellular carcinoma
H. Michael Shepard
|
|
 |
Molecular therapy for hematopoietic and solid tumor neoplasms
Albert B. Deisseroth
Sidney Kimmel Cancer Center., USA
|
|
|
|
|
 |
Development of bioactive peptides through peptide libraries
Chi-Bom Chae
Pohang Univ. of Science & Technology,
Korea |
|
|
|
|
|